Skip to content
FIND A HEALTH VALLEY ACTOR

Smart Shoes to Help Prevent Diabetic Foot Amputations

Zoltan Pataky

Professor Zoltan Pataky from University of Geneva, has received major funding from the Swiss National Science Foundation (SNSF) to conduct clinical testing on smart shoes designed to prevent foot ulcers in people with diabetes — a leading cause of lower limb amputation.   Each year, diabetes leads to an estimated 250,000 amputations in Europe, 85%…

Read More

AzureCell Therapies Secures Innosuisse Grant to Advance Parkinson Disease Treatment

Azure Cell Therapies

AzureCell Therapies, a University of Geneva spinoff at the forefront of regenerative medicine, has been awarded a CHF 650,000 grant from Innosuisse, Switzerland’s innovation agency, to advance its pioneering cell-replacement therapies for Parkinson’s disease.   Rooted in over 20 years of research from the University of Geneva and backed by over CHF 8 million in…

Read More

LaxiPed Secures Innosuisse Grant to Revolutionise Foot Orthopaedics with Precision Diagnostics

LaxiPed Web

LaxiPed, a Geneva-based life sciences project, has received an Innosuisse grant of CHF 679,000 to support the clinical validation of its innovative diagnostic device for foot orthopaedics. This key milestone will allow the team to take the next step toward improving diagnosis, surgical planning, and patient outcomes for conditions such as hallux valgus (bunion)—a highly…

Read More

CHUV inaugurates its Bladder Cancer Center

Chuv Blader Cancer Center

Inaugurated on 1 June 2025, the Bladder Cancer Center is the eleventh interdisciplinary oncology center created at the University Hospital of Vaud (CHUV). It aims to improve the quality and safety of care by offering patients state-of-the-art treatment combining specialized surgery, innovative systemic therapies, and a rehabilitation programme.     Every year in Switzerland, bladder…

Read More

Innosanté

Innosanté Neuchâtel

Innosanté is taking place on 2 October 2025 in Neuchâtel   SMEs, startups, large companies, and research centers, as well as healthcare professionals and healthcare institutions, are invited to meet on October 2, 2025, in Neuchâtel for a day of reflection and discussion. The discussions will focus on several key questions: How can innovation strengthen…

Read More

Switzerland Innovation Parks and Microsoft Collaboration for AI-Powered Solutions

Switzerland Innovation Park

The Switzerland Innovation Parks and Microsoft have announced a collaboration to accelerate the development and deployment of AI-powered solutions across Switzerland. The collaboration aims to empower startups and SMEs by embedding cutting-edge AI capabilities into the country’s leading innovation environments.     This initiative will be implemented locally through the six Switzerland Innovation Parks that…

Read More

Atinary Technologies Gets Funding to Accelerate Antibiotics Discovery with AI

Atinary Technologies

Atinary Technologies, a pioneering Swiss deeptech startup, has announced its participation in a groundbreaking project funded by AIchemy, a UK-based initiative supported by the Engineering and Physical Sciences Research Council. In partnership with the Frei Lab at the University of York, Atinary is set to transform antibiotic discovery by focusing on a promising yet underexplored…

Read More

DePoly gets a Economic Award

DePoly

DePoly gets the Swiss Economic Award 2025 in the “Deeptech / Life Science” category, with a CHF 25’000 cash prize.   The award ceremony took place this Friday in Interlaken, attended by part of the Sion-based startup team and representatives from the political and economic spheres. DePoly’s innovative technology breaks down PET and polyester into…

Read More

Switzerland Invests CHF 666 Million to Join European Research Programmes

Horizon

Fantastic news for the Swiss Health Valley and the Swiss scientific community! On 4 June 2025, the Swiss Parliament approved an additional CHF 666 million to support Switzerland’s full participation in key European research and innovation programmes — including Horizon Europe, Euratom, and Digital Europe.     Switzerland must be able to participate in European…

Read More

BrainQuant SA Revolutionizes Neurodegenerative Diseases Detection

BrainQuant SA

BrainQuant SA is a Wyss Center Geneva spin-off co-founded in partnership with EPFL, University of Geneva (UNIGE), and HCK Healthcare Konnect. The new company, led by internationally recognized experts in neuroradiology, bioengineering, and digital health, is poised to transform how neurodegenerative diseases are detected.   BrainQuant harnesses the power of artificial intelligence to analyze Arterial…

Read More